The global glucose excipient market is estimated to be valued at US$ 5,863.3 Mn in 2023 and is expected to exhibit a CAGR of 8.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Glucose excipients are commonly used as bulking agents, binders and fillers in oral formulations like tablets and capsules. They help improve the flow properties of powder blends for tableting and increase the bulk volume of capsules. The demand for oral drug delivery is growing exponentially owing to non-invasive nature and convenience of self-administration. This has spurred the need for excipients like glucose that are compliant with various quality standards and offer technical advantages.
Market key trends:
The rising demand for oral drugs is one of the major factors propelling the glucose excipient market growth. Glucose finds wide application as an excipient in formulations for diabetic drugs, anti-infectives and analgesics which are among the highest selling oral drug classes. Its inert profile and ease of use makes it compatible for formulating various active pharmaceutical ingredients. Further, glucose is generally recognized as safe by regulatory agencies and conforms to pharmaceutical grade requirements. This reduces product development timelines and ensures compliance. Also, manufacturers are offering versatile grades of glucose excipients tailored for specific drug delivery systems such as immediate release and controlled release tablets. This is anticipated to drive preference over the forecast period.
SWOT Analysis
Strength: Glucose excipient has wide applications in dental and medical areas. It is commonly used as a diluent in many pharmaceutical formulations due to its stability and compatibility properties.
Weakness: High cost of customized materials compared to standard products. Dependence on limited raw material suppliers can impact production.
Opportunity: Growing aging population and increasing focus on dental aesthetics and cosmetic dentistry are driving the demand. Rising medical tourism in developing regions also offers new opportunities.
Threats: Stringent regulations associated with materials biocompatibility and safety. Competition from substitute materials limiting market growth.
Key Takeaways
The global glucose excipient market is expected to witness high growth driven by increasing dental aesthetics procedures, growing aging population and rising emphasis on oral healthcare.
Regional analysis: The global glucose excipient market is expected to witness highest growth in Asia Pacific region due to rapidly growing dental industry and medical tourism hub in countries like India and China. North America currently dominates the market owing to well-established dental and healthcare infrastructure and presence of major players.
Key players: Key players operating in the glucose excipient market are Polident D.O.O., Amt Medical SRL, Ivoclar Vivadent, VITA Zahnfabrik H. Rauter GmbH & Co. KG., Merz Dental GmbH, 3D Diagnostix Inc., Medical Precision Implants, FSM Dental Medikal Mak. San. Tic. Ltd. Sti., Yamahachi Dental Mfg., Co., Glidewell, Anthogyr SAS, Dentsply Sirona, 3Shape, Zimmer Biomet, SprintRay Inc., Thommen Medical AG, Institut Straumann AG, and Henry Schein, Inc.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it